Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London pre-open: G7 warns of Brexit risks

Fri, 27th May 2016 07:29

(ShareCast News) - Stocks are set for a slightly lower open as traders tread cautiously ahead of a speech by Fed chair Janet Yellen towards the close of trading in London and ahead of the release of key economic indicators Stateside.The fact that investors are heading into a long weekend on both sides of the Pond, ahead of key risk events next week including the US jobs report for May and an OPEC summit is also expected to restrain activity today.With little doubt, all eyes are on Yellen´s speech at Harvard University, which is scheduled for 15:30BST; although the possibility exists that she will not make policy relevant remarks, even the risk that she might is enough to keep many traders on the sidelines.The Footsie is seen starting the day 3 points higher from Thursday closing mark of 6,265.65."At the moment, it is all about Miss Yellen and all focus will be on her as she takes to the stage later today. Many think that she will be very hawkish and possibly reverberate the same message as her fellow colleagues; that the US economy warrants another rate hike," said Naeem Aslam, chief market analyst at Think Forex UK."We don't think it's the right venue," said Michael Gapen, chief US economist at Barclays Investment Bank. "I would be surprised if she made comments."Any comments would come after a hawkish set of FOMC minutes last week and several Fed governors adding since then that two to three rate hikes were on the table in 2016, possibly including at the next meeting, on 14-15 June.Acting as a backdrop, following their meeting at Ise-Shima, in central Japan, G7 leaders warned of the damage that Brexit might inflict."A UK exit from the EU would reverse the trend towards greater global trade and investment, and the jobs they create, and is a further serious risk to growth," they said in an official statement.The main Asian stock gauges are broadly higher, with the Shanghai Stock Exchange´s Composite Index standing 0.22% higher at 2,828.57 as of 07:30 BST.To take note of, reports indicate that Japanese prime minister Shinzo Abe might announce a decision to postpone a planned increase in the country´s consumption tax in April 2017.Linked to the above, figures released overnight revealed that core consumer prices in the Tokyo area - a lead indicator for price pressures in the world´s third-largest economy - slipped to a -0.5% year-on-year clip in May (consensus: -0.4%).On the data front, the main releases on Friday will be a second reading on US first quarter GDP at 13:30 BST followed ninety minutes later by the University of Michigan´s consumer confidence survey results for the end of May.Finance post up for grabs at WolseleyWolseley said on Friday that Simon Nicholls will not take up his role as chief financial officer later this year, as announced back in January, without giving any reasons. The FTSE 100 building materials group said David Keltner, current CFO of US subsidiary Ferguson Enterprises, will be appointed interim group CFO on 1 September and the selection process to appoint a permanent CFO will commence immediately. The company confirmed Ian Meakins will retire on 31 August 2016, while John Martin will succeed him as CEO on the 1 September as expected.Phamaceuticals giant AstraZeneca announced positive results for its Faslodex drug for the treatment of metastatic breast cancer in post-menopausal women who have not had prior hormonal treatment for home-receptor-positive breast cancer. The company said on Friday that Faslodex met its primary endpoint of extended progression-free survival.In addition, AZN said the US Food & Drug Administration has issued a complete response letter on the new drug application made for sodium zirconium cyclosilicate, the investigational medicine being developed for the treatment of hyperkalaemia (high potassium level in the blood serum) by wholly-owned subsidiary ZS Pharma.
More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.